10-Q · 2026-11-12
Taysha Gene Therapies, Inc. reports Q3 results, emphasizing advancements in gene therapy. Key competitors include Astellas and Abeona Therapeutics.
| Name | Taysha Gene Therapies, Inc. |
|---|---|
| CIK | 0001806310 |
| Tickers | TSHA |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 843199512 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (214) 612-0000 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Taysha Gene Therapies, Inc. reports Q3 results, emphasizing advancements in gene therapy. Key competitors include Astellas and Abeona Therapeutics.
Taysha Gene Therapies shares third-quarter results and updates on TSHA-102 for Rett syndrome, moving towards a potential BLA submission in 2027.
404 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001346824-26-000295 | 005-91724 | 261563037 | 34 | 15549 | |||
| 2026-11-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-456974 | 001-39536 | 261543270 | 34 | 230277 | 1 | 1 |
| 2026-11-12 | 10-Q | 10-Q | 0001193125-26-456949 | 001-39536 | 261543211 | 34 | 15958269 | 1 | 1 | |
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001231919-26-000928 | 005-91724 | 261283107 | 34 | 15604 | |||
| 2026-08-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000895421-26-000269 | 005-91724 | 261275141 | 34 | 12043 | |||
| 2026-08-11 | 10-Q | 10-Q | 0001193125-26-344610 | 001-39536 | 261263209 | 34 | 15375549 | 1 | 1 | |
| 2026-08-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-344594 | 001-39536 | 261263145 | 34 | 242304 | 1 | 1 |
| 2026-07-10 | 4 | xslF345X06/form4-07102026_100732.xml | 0001665124-26-000013 | 5502 | ||||||
| 2026-07-10 | 144 | xsl144X01/primary_doc.xml | 0001974158-26-000076 | 001-39536 | 261168963 | 33 | 5831 | |||
| 2026-06-25 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-26-282855 | 001-39536 | 261122251 | 34 | 541878 | 1 | 1 |
| 2026-06-25 | 424B5 | 424B5 | 0001193125-26-282846 | 333-291244 | 261122225 | 33 | 2836404 | 1 | 1 | |
| 2026-06-24 | 424B5 | 424B5 | 0001193125-26-281288 | 333-291244 | 261116900 | 33 | 2692028 | |||
| 2026-06-22 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-26-276738 | 001-39536 | 261105007 | 34 | 4484848 | 1 | 1 |
| 2026-06-02 | 4 | xslF345X06/form4-06022026_040616.xml | 0001709418-26-000002 | 8481 | ||||||
| 2026-06-02 | 4 | xslF345X06/form4-06022026_040614.xml | 0001238120-26-000008 | 7553 | ||||||
| 2026-06-02 | 4 | xslF345X06/form4-06022026_040612.xml | 0001891712-26-000002 | 7441 | ||||||
| 2026-06-02 | 4 | xslF345X06/form4-06022026_040610.xml | 0001777421-26-000005 | 7470 | ||||||
| 2026-06-02 | 8-K | 8-K | 5.07 | 0001193125-26-253478 | 001-39536 | 261055898 | 34 | 152724 | 1 | 1 |
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000902664-26-002553 | 005-91724 | 26989663 | 34 | 10940 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001493215-26-000122 | 005-91724 | 26982614 | 34 | 10693 | |||
| 2026-05-06 | 10-Q | 10-Q | 0001193125-26-207666 | 001-39536 | 26945944 | 34 | 9737718 | 1 | 1 | |
| 2026-05-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-207633 | 001-39536 | 26945910 | 34 | 224613 | 1 | 1 |
| 2026-04-22 | ARS | ARS | 0001193125-26-168538 | 001-39536 | 26881331 | 34 | 12068726 | |||
| 2026-04-22 | DEFA14A | DEFA14A | 0001193125-26-168533 | 001-39536 | 26881327 | 34 | 979597 | |||
| 2026-04-22 | DEF 14A | DEF 14A | 0001193125-26-168525 | 001-39536 | 26881323 | 34 | 2834696 | 1 | 1 | |
| 2026-04-13 | 4 | xslF345X06/form4-04132026_080454.xml | 0001665124-26-000011 | 9450 | ||||||
| 2026-04-10 | 144 | xsl144X01/primary_doc.xml | 0001974158-26-000040 | 001-39536 | 26854984 | 33 | 6358 | |||
| 2026-03-19 | 10-K | 10-K | 0001193125-26-115202 | 001-39536 | 26772532 | 34 | 19866549 | 1 | 1 | |
| 2026-03-19 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-115177 | 001-39536 | 26772480 | 34 | 225875 | 1 | 1 |
| 2026-02-27 | 144 | xsl144X01/primary_doc.xml | 0002086827-26-000008 | 001-39536 | 26699733 | 33 | 7102 | |||
| 2026-02-17 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-26-001081 | 005-91724 | 26641058 | 34 | 14899 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001493215-26-000050 | 005-91724 | 26636800 | 34 | 10745 | |||
| 2026-02-06 | 4 | xslF345X05/form4-02062026_040223.xml | 0001793412-26-000012 | 4900 | ||||||
| 2026-02-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-26-000536 | 005-91724 | 26602068 | 34 | 11485 | |||
| 2026-02-04 | 144 | xsl144X01/primary_doc.xml | 0001977343-26-000005 | 001-39536 | 26599776 | 33 | 6453 | |||
| 2026-02-04 | 144 | xsl144X01/primary_doc.xml | 0001979666-26-000006 | 001-39536 | 26599773 | 33 | 6454 | |||
| 2026-02-04 | 144 | xsl144X01/primary_doc.xml | 0001979693-26-000007 | 001-39536 | 26599767 | 33 | 6434 | |||
| 2026-02-04 | 144 | xsl144X01/primary_doc.xml | 0002086827-26-000006 | 001-39536 | 26599758 | 33 | 6336 | |||
| 2026-02-04 | 144 | xsl144X01/primary_doc.xml | 0001793412-26-000010 | 001-39536 | 26599751 | 33 | 6253 | |||
| 2026-01-27 | 4 | xslF345X05/form4-01272026_040105.xml | 0001665124-26-000008 | 7232 | ||||||
| 2026-01-27 | 4 | xslF345X05/form4-01272026_040103.xml | 0001569926-26-000008 | 8184 | ||||||
| 2026-01-27 | 4 | xslF345X05/form4-01272026_040101.xml | 0001793412-26-000008 | 7161 | ||||||
| 2026-01-23 | 144 | xsl144X01/primary_doc.xml | 0001569926-26-000006 | 001-39536 | 26558234 | 33 | 4861 | |||
| 2026-01-23 | 144 | xsl144X01/primary_doc.xml | 0001665124-26-000006 | 001-39536 | 26558230 | 33 | 6260 | |||
| 2026-01-23 | 144 | xsl144X01/primary_doc.xml | 0002086827-26-000004 | 001-39536 | 26558228 | 33 | 4809 | |||
| 2026-01-23 | 144 | xsl144X01/primary_doc.xml | 0001979666-26-000004 | 001-39536 | 26558227 | 33 | 4931 | |||
| 2026-01-23 | 144 | xsl144X01/primary_doc.xml | 0001977343-26-000003 | 001-39536 | 26558225 | 33 | 4935 | |||
| 2026-01-23 | 144 | xsl144X01/primary_doc.xml | 0001979693-26-000005 | 001-39536 | 26558220 | 33 | 4915 | |||
| 2026-01-23 | 144 | xsl144X01/primary_doc.xml | 0001793412-26-000006 | 001-39536 | 26558218 | 33 | 4740 | |||
| 2026-01-21 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-26-000794 | 005-91724 | 26545984 | 34 | 10962 | |||
| 2026-01-14 | 4 | xslF345X05/form4-01142026_040105.xml | 0001793412-26-000002 | 7394 | ||||||
| 2026-01-14 | 4 | xslF345X05/form4-01142026_040103.xml | 0001569926-26-000002 | 8399 | ||||||
| 2026-01-14 | 4 | xslF345X05/form4-01142026_040101.xml | 0001665124-26-000002 | 17443 | ||||||
| 2026-01-12 | 144 | xsl144X01/primary_doc.xml | 0001974158-26-000011 | 001-39536 | 26526929 | 33 | 6483 | |||
| 2026-01-06 | S-8 | S-8 | 0001193125-26-004622 | 333-292589 | 26512226 | 33 | 241158 | 1 | 1 | |
| 2025-12-01 | 4 | xslF345X05/form4-12022025_011240.xml | 0001665124-25-000003 | 18340 | ||||||
| 2025-11-28 | 144 | xsl144X01/primary_doc.xml | 0001974158-25-000077 | 001-39536 | 251534388 | 33 | 5504 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001214659-25-016718 | 005-91724 | 251487626 | 34 | 10941 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001231919-25-000491 | 005-91724 | 251486615 | 34 | 15365 | |||
| 2025-11-04 | S-3ASR | S-3ASR | 0001193125-25-263634 | 333-291244 | 251446592 | 33 | 1472909 | 1 | 1 | |
| 2025-11-04 | 8-K | 8-K | 1.01,2.02,9.01 | 0001193125-25-263543 | 001-39536 | 251446430 | 34 | 329188 | 1 | 1 |
| 2025-11-04 | 10-Q | 10-Q | 0001193125-25-263506 | 001-39536 | 251446346 | 34 | 16807875 | 1 | 1 | |
| 2025-10-16 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-241415 | 001-39536 | 251397729 | 34 | 165427 | 1 | 1 |
| 2025-10-09 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-235212 | 001-39536 | 251383651 | 34 | 170641 | 1 | 1 |
| 2025-10-02 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-227505 | 001-39536 | 251367069 | 34 | 169980 | 1 | 1 |
| 2025-09-22 | 144 | xsl144X01/primary_doc.xml | 0002086827-25-000002 | 001-39536 | 251331303 | 33 | 4796 | |||
| 2025-09-12 | 4 | xslF345X05/form4-09122025_040917.xml | 0001415889-25-024369 | 9250 | ||||||
| 2025-09-10 | 144 | xsl144X01/primary_doc.xml | 0001974158-25-000058 | 001-39536 | 251306173 | 33 | 6388 | |||
| 2025-08-22 | 4 | xslF345X05/form4-08222025_040806.xml | 0001415889-25-022750 | 5414 | ||||||
| 2025-08-22 | 4 | xslF345X05/form4-08222025_040804.xml | 0001415889-25-022749 | 5361 | ||||||
| 2025-08-21 | 144 | xsl144X01/primary_doc.xml | 0001415889-25-022689 | 001-39536 | 251242069 | 33 | 4728 | |||
| 2025-08-21 | 144 | xsl144X01/primary_doc.xml | 0001415889-25-022687 | 001-39536 | 251242068 | 33 | 4923 | |||
| 2025-08-21 | 144 | xsl144X01/primary_doc.xml | 0001415889-25-022685 | 001-39536 | 251242066 | 33 | 4873 | |||
| 2025-08-21 | 144 | xsl144X01/primary_doc.xml | 0001415889-25-022683 | 001-39536 | 251242060 | 33 | 4903 | |||
| 2025-08-21 | 144 | xsl144X01/primary_doc.xml | 0001415889-25-022681 | 001-39536 | 251242058 | 33 | 4920 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-022033 | 005-91724 | 251221574 | 34 | 15551 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-021712 | 005-91724 | 251214494 | 34 | 10941 | |||
| 2025-08-12 | 10-Q | 10-Q | 0000950170-25-107010 | 001-39536 | 251205003 | 34 | 14033270 | 1 | 1 | |
| 2025-08-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-178504 | 001-39536 | 251204141 | 34 | 244573 | 1 | 1 |
| 2025-08-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000895421-25-000463 | 005-91724 | 251188917 | 34 | 12022 | |||
| 2025-08-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-002098 | 005-91724 | 251188460 | 34 | 11101 | |||
| 2025-07-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-002549 | 005-91724 | 251128502 | 34 | 10895 | |||
| 2025-07-03 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000769993-25-000401 | 005-91724 | 251104496 | 34 | 15746 | |||
| 2025-06-04 | 4 | xslF345X05/form4-06042025_040609.xml | 0001415889-25-015574 | 8348 | ||||||
| 2025-06-04 | 4 | xslF345X05/form4-06042025_040607.xml | 0001415889-25-015573 | 7420 | ||||||
| 2025-06-04 | 4 | xslF345X05/form4-06042025_040604.xml | 0001415889-25-015572 | 7308 | ||||||
| 2025-06-04 | 4 | xslF345X05/form4-06042025_040601.xml | 0001415889-25-015571 | 7337 | ||||||
| 2025-06-03 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001415889-25-015487 | 005-91724 | 251021799 | 34 | 20556 | |||
| 2025-06-03 | 4 | xslF345X05/form4-06042025_010624.xml | 0001415889-25-015480 | 9486 | ||||||
| 2025-06-03 | 8-K | 8-K | 5.03,5.07,9.01 | 0001193125-25-133745 | 001-39536 | 251017133 | 34 | 164287 | 1 | 1 |
| 2025-05-29 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-25-130709 | 001-39536 | 251004092 | 34 | 1688455 | 1 | 1 |
| 2025-05-29 | 424B5 | 424B5 | 0001193125-25-130693 | 333-283801 | 251003984 | 33 | 2699602 | |||
| 2025-05-29 | 8-K/A | 8-K/A | 7.01,8.01,9.01 | 0001193125-25-129849 | 001-39536 | 25997532 | 34 | 14128268 | 1 | 1 |
| 2025-05-28 | 424B5 | 424B5 | 0001193125-25-129569 | 333-283801 | 25996230 | 33 | 2701880 | |||
| 2025-05-28 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-129494 | 001-39536 | 25995553 | 34 | 4368482 | 1 | 1 |
| 2025-05-15 | 10-Q | 10-Q | 0000950170-25-072036 | 001-39536 | 25948976 | 34 | 10197823 | 1 | 1 | |
| 2025-05-15 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-120329 | 001-39536 | 25948839 | 34 | 228396 | 1 | 1 |
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-072014 | 005-91724 | 25948801 | 34 | 11026 | |||
| 2025-05-09 | DEFR14A | DEFR14A | 0001193125-25-116882 | 001-39536 | 25930383 | 34 | 239336 | 1 | 1 | |
| 2025-04-21 | ARS | ARS | 0001193125-25-087223 | 001-39536 | 25853164 | 34 | 3805114 | |||
| 2025-04-21 | DEFA14A | DEFA14A | 0001193125-25-087216 | 001-39536 | 25853089 | 34 | 317270 | |||
| 2025-04-21 | DEF 14A | DEF 14A | 0001193125-25-087214 | 001-39536 | 25853059 | 34 | 1526932 | 1 | 1 | |
| 2025-04-10 | 4/A | xslF345X05/form4a-04102025_040408.xml | 0001415889-25-010539 | 5813 | ||||||
| 2025-04-10 | PRE 14A | PRE 14A | 0001193125-25-077943 | 001-39536 | 25828314 | 34 | 1534903 | 1 | 1 | |
| 2025-03-13 | 4 | xslF345X05/form4-03132025_040301.xml | 0001415889-25-007997 | 4903 | ||||||
| 2025-02-26 | 10-K | 10-K | 0000950170-25-027348 | 001-39536 | 25666309 | 34 | 22251205 | 1 | 1 | |
| 2025-02-26 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-035882 | 001-39536 | 25666238 | 34 | 228262 | 1 | 1 |
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-020476 | 005-91724 | 25623657 | 34 | 10872 | |||
| 2025-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-000808 | 005-91724 | 25612444 | 34 | 11626 | |||
| 2025-02-05 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001214659-25-002035 | 005-91724 | 25594795 | 34 | 10767 | |||
| 2025-02-05 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000895421-25-000244 | 005-91724 | 25591381 | 34 | 11918 | |||
| 2025-01-07 | S-8 | S-8 | 0001193125-25-002868 | 333-284167 | 25515279 | 33 | 97248 | |||
| 2025-01-03 | 4 | xslF345X05/form4-01032025_100137.xml | 0001415889-25-000599 | 8678 | ||||||
| 2025-01-03 | 4 | xslF345X05/form4-01032025_100136.xml | 0001415889-25-000597 | 7727 | ||||||
| 2025-01-03 | 4 | xslF345X05/form4-01032025_100118.xml | 0001415889-25-000595 | 7656 | ||||||
| 2024-12-20 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-24-003902 | 333-283801 | 241569593 | 33 | 1796 | ||
| 2024-12-20 | CORRESP | filename1.htm | 0001193125-24-282474 | 8023 | ||||||
| 2024-12-19 | CORRESP | filename1.htm | 0001193125-24-282002 | 7976 | ||||||
| 2024-12-18 | UPLOAD | filename1.pdf | 0000000000-24-013975 | 333-283801 | 40102 | |||||
| 2024-12-13 | S-3 | S-3 | 0001193125-24-278466 | 333-283801 | 241548372 | 33 | 1378346 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-119336 | 005-91724 | 241464793 | 34 | 157060 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-119297 | 005-91724 | 241464736 | 34 | 88744 | |||
| 2024-11-14 | SC 13G | TAYSHA GENE THERAPIES, INC. | 0000902664-24-006533 | 005-91724 | 241457867 | 34 | 64972 | |||
| 2024-11-13 | 10-Q | 10-Q | 0000950170-24-126416 | 001-39536 | 241455064 | 34 | 12512025 | 1 | 1 | |
| 2024-11-13 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-257205 | 001-39536 | 241454265 | 34 | 255833 | 1 | 1 |
| 2024-11-12 | SC 13G/A | filing.txt | 0000315066-24-002879 | 005-91724 | 241444994 | 34 | 8261 | |||
| 2024-11-08 | SC 13G | us8776191061_110824.txt | 0002012383-24-003575 | 005-91724 | 241439701 | 34 | 13768 | |||
| 2024-10-22 | SC 13G | us8776191061_102224.txt | 0002012383-24-001567 | 005-91724 | 241387279 | 34 | 13754 | |||
| 2024-08-12 | 10-Q | 10-Q | 0000950170-24-095082 | 001-39536 | 241195005 | 34 | 12210992 | 1 | 1 | |
| 2024-08-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-198392 | 001-39536 | 241194797 | 34 | 248904 | 1 | 1 |
| 2024-07-05 | 144 | xsl144X01/primary_doc.xml | 0001231919-24-000053 | 001-39536 | 241103166 | 33 | 4721 | |||
| 2024-07-05 | 144 | xsl144X01/primary_doc.xml | 0001231919-24-000052 | 001-39536 | 241103165 | 33 | 4691 | |||
| 2024-07-05 | 144 | xsl144X01/primary_doc.xml | 0001231919-24-000051 | 001-39536 | 241103163 | 33 | 4698 | |||
| 2024-07-01 | 4 | xslF345X05/form4-07012024_080703.xml | 0001415889-24-018515 | 8700 | ||||||
| 2024-06-26 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-24-169191 | 001-39536 | 241074510 | 34 | 614236 | 1 | 1 |
| 2024-06-26 | 424B5 | 424B5 | 0001193125-24-169188 | 333-260069 | 241074479 | 33 | 1940474 | |||
| 2024-06-26 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-24-168479 | 001-39536 | 241070562 | 34 | 1402676 | 1 | 1 |
| 2024-06-26 | 424B5 | 424B5 | 0001193125-24-168470 | 333-260069 | 241070555 | 33 | 1941652 | |||
| 2024-06-18 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-163050 | 001-39536 | 241050199 | 34 | 4464754 | 1 | 1 |
| 2024-05-31 | 4 | xslF345X05/form4-05312024_040510.xml | 0001415889-24-015041 | 8351 | ||||||
| 2024-05-31 | 4 | xslF345X05/form4-05312024_040508.xml | 0001415889-24-015040 | 7310 | ||||||
| 2024-05-31 | 4 | xslF345X05/form4-05312024_040505.xml | 0001415889-24-015039 | 7423 | ||||||
| 2024-05-31 | 4 | xslF345X05/form4-05312024_040501.xml | 0001415889-24-015038 | 7339 | ||||||
| 2024-05-30 | 8-K | 8-K | 5.07 | 0001193125-24-150323 | 001-39536 | 241005090 | 34 | 154401 | 1 | 1 |
| 2024-05-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-138253 | 001-39536 | 24944625 | 34 | 234177 | 1 | 1 |
| 2024-05-14 | 10-Q | 10-Q | 0000950170-24-059555 | 001-39536 | 24944479 | 34 | 9483239 | 1 | 1 | |
| 2024-04-18 | DEFA14A | DEFA14A | 0001193125-24-100817 | 001-39536 | 24854564 | 34 | 592452 | |||
| 2024-04-18 | ARS | ARS | 0001193125-24-100808 | 001-39536 | 24854529 | 34 | 2128213 | |||
| 2024-04-18 | DEF 14A | DEF 14A | 0001193125-24-100792 | 001-39536 | 24854453 | 34 | 433009 | |||
| 2024-03-19 | S-8 | S-8 | 0001193125-24-071452 | 333-278070 | 24764672 | 33 | 81611 | |||
| 2024-03-19 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-071321 | 001-39536 | 24763466 | 34 | 254666 | 1 | 1 |
| 2024-03-19 | 10-K | 10-K | 0000950170-24-033484 | 001-39536 | 24763415 | 34 | 12845308 | 1 | 1 | |
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-024220 | 005-91724 | 24641684 | 34 | 156754 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-024005 | 005-91724 | 24640149 | 34 | 92636 | |||
| 2024-02-14 | SC 13G | TAYSHA GENE THERAPIES, INC. | 0000902664-24-001544 | 005-91724 | 24632231 | 34 | 66220 | |||
| 2024-02-09 | SC 13G/A | SC 13G/A | 0001193125-24-030082 | 005-91724 | 24615396 | 34 | 57817 | |||
| 2024-02-09 | SC 13G/A | filing.txt | 0000315066-24-001456 | 005-91724 | 24612049 | 34 | 8290 | |||
| 2024-02-06 | 4 | xslF345X05/form4-02062024_090255.xml | 0001415889-24-002809 | 4886 | ||||||
| 2024-01-10 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-005637 | 001-39536 | 24524898 | 34 | 170045 | 1 | 1 |
| 2024-01-04 | 4 | FORM 4 SUBMISSION | 0001209191-24-000811 | 7533 | ||||||
| 2024-01-04 | 4 | FORM 4 SUBMISSION | 0001209191-24-000809 | 7605 | ||||||
| 2024-01-04 | 4 | FORM 4 SUBMISSION | 0001209191-24-000807 | 8561 | ||||||
| 2023-12-20 | 8-K | 8-K | 5.02,9.01 | 0001193125-23-299942 | 001-39536 | 231501541 | 34 | 452622 | 1 | 1 |
| 2023-12-20 | S-8 | S-8 | 0001193125-23-299939 | 333-276161 | 231501526 | 33 | 307092 | |||
| 2023-12-18 | 4 | FORM 4 SUBMISSION | 0001209191-23-058977 | 5815 | ||||||
| 2023-12-18 | 4 | FORM 4 SUBMISSION | 0001209191-23-058973 | 5887 | ||||||
| 2023-12-18 | 4 | FORM 4 SUBMISSION | 0001209191-23-058971 | 5863 | ||||||
| 2023-11-20 | 4 | FORM 4 SUBMISSION | 0001209191-23-055942 | 8588 | ||||||
| 2023-11-15 | 8-K | 8-K | 5.03,5.07,9.01 | 0001193125-23-277914 | 001-39536 | 231410967 | 34 | 165888 | 1 | 1 |
| 2023-11-14 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-277165 | 001-39536 | 231407425 | 34 | 253536 | 1 | 1 |
| 2023-11-14 | 10-Q | 10-Q | 0000950170-23-063734 | 001-39536 | 231406595 | 34 | 13490758 | 1 | 1 | |
| 2023-11-03 | 4 | FORM 4 SUBMISSION | 0001209191-23-054339 | 5485 | ||||||
| 2023-11-03 | 3 | FORM 3 SUBMISSION | 0001209191-23-054336 | 6620 | ||||||
| 2023-11-01 | 8-K | 8-K | 5.02 | 0001193125-23-268173 | 001-39536 | 231368114 | 34 | 155103 | 1 | 1 |
| 2023-10-05 | DEF 14A | DEF 14A | 0001193125-23-251065 | 001-39536 | 231309796 | 34 | 231799 | |||
| 2023-09-26 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-241943 | 001-39536 | 231277198 | 34 | 169555 | 1 | 1 |
| 2023-09-21 | PRE 14A | PRE 14A | 0001193125-23-239550 | 001-39536 | 231269136 | 34 | 231916 | |||
| 2023-09-19 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-237632 | 001-39536 | 231263803 | 34 | 166626 | 1 | 1 |
| 2023-09-11 | 424B3 | 424B3 | 0001193125-23-232444 | 333-274264 | 231247725 | 33 | 252481 | |||
| 2023-09-11 | SC 13G/A | filing.txt | 0000315066-23-002575 | 005-91724 | 231246766 | 34 | 8207 | |||
| 2023-09-08 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-09-08 16:00:00 | 9999999995-23-002613 | 333-274264 | 231246562 | 33 | 1747 | ||
| 2023-09-07 | CORRESP | filename1.htm | 0001193125-23-230112 | 7020 | ||||||
| 2023-09-06 | UPLOAD | filename1.pdf | 0000000000-23-009862 | 40287 | ||||||
| 2023-08-30 | S-3 | S-3 | 0001193125-23-224918 | 333-274264 | 231225245 | 33 | 343544 | |||
| 2023-08-29 | 8-K | 8-K | 8.01 | 0001193125-23-222964 | 001-39536 | 231218029 | 34 | 147425 | 1 | 1 |
| 2023-08-28 | SC 13G | SC 13G | 0001104659-23-096003 | 005-91724 | 231215723 | 34 | 192712 | |||
| 2023-08-25 | SC 13G | SC 13G | 0001104659-23-095393 | 005-91724 | 231209154 | 34 | 88335 | |||
| 2023-08-25 | 4 | FORM 4 SUBMISSION | 0001209191-23-047323 | 5498 | ||||||
| 2023-08-25 | D | xslFormDX01/primary_doc.xml | 06b | 0001231919-23-000063 | 021-490724 | 231208733 | 33 | 13244 | ||
| 2023-08-25 | SC 13G | SC 13G | 0001193125-23-221528 | 005-91724 | 231208635 | 34 | 76616 | |||
| 2023-08-24 | 144 | xsl144X01/primary_doc.xml | 0001968582-23-000435 | 001-39536 | 231203133 | 33 | 4343 | |||
| 2023-08-24 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-219580 | 001-39536 | 231198943 | 34 | 177068 | 1 | 1 |
| 2023-08-21 | SC 13D/A | SC 13D/A | 0001193125-23-216942 | 005-91724 | 231189098 | 34 | 117466 | |||
| 2023-08-18 | SC 13D/A | SC 13D/A | 0001193125-23-216053 | 005-91724 | 231186706 | 34 | 115777 | |||
| 2023-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-046154 | 8370 | ||||||
| 2023-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-046152 | 8083 | ||||||
| 2023-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-046150 | 5595 | ||||||
| 2023-08-16 | 4 | FORM 4 SUBMISSION | 0001209191-23-046148 | 4668 | ||||||
| 2023-08-14 | 10-Q | 10-Q | 0000950170-23-042089 | 001-39536 | 231166534 | 34 | 30355987 | 1 | 1 | |
| 2023-08-14 | 8-K | 8-K | 1.01,2.02,3.02,8.01,9.01 | 0001193125-23-211456 | 001-39536 | 231166256 | 34 | 662023 | 1 | 1 |
| 2023-08-04 | 8-K | 8-K | 3.01 | 0001193125-23-203836 | 001-39536 | 231143931 | 34 | 152993 | 1 | 1 |
| 2023-07-31 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-198580 | 001-39536 | 231125089 | 34 | 168748 | 1 | 1 |
| 2023-07-14 | 4 | 4 | 0000950170-23-032986 | 7878 | ||||||
| 2023-06-28 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-176864 | 001-39536 | 231049347 | 34 | 187888 | 1 | 1 |
| 2023-06-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-039733 | 5459 | ||||||
| 2023-06-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-039732 | 5435 | ||||||
| 2023-06-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-039731 | 5542 | ||||||
| 2023-06-26 | 4 | FORM 4 SUBMISSION | 0001209191-23-039730 | 5541 | ||||||
| 2023-06-26 | 3 | FORM 3 SUBMISSION | 0001209191-23-039728 | 8295 | ||||||
| 2023-06-26 | 4 | FORM 4 SUBMISSION | 0000899243-23-016491 | 8777 | ||||||
| 2023-06-23 | 8-K | 8-K | 5.07 | 0001193125-23-173983 | 001-39536 | 231038790 | 34 | 159328 | 1 | 1 |
| 2023-06-22 | 8-K | 8-K | 5.02 | 0001193125-23-172678 | 001-39536 | 231034155 | 34 | 157139 | 1 | 1 |
| 2023-06-22 | 4 | FORM 4 SUBMISSION | 0000899243-23-016232 | 8776 | ||||||
| 2023-06-20 | 144/A | xsl144X01/primary_doc.xml | 0001968582-23-000266 | 001-39536 | 231027007 | 33 | 4461 | |||
| 2023-06-20 | 144 | xsl144X01/primary_doc.xml | 0001968582-23-000263 | 001-39536 | 231025958 | 33 | 4313 | |||
| 2023-06-06 | 8-K | 8-K | 5.02 | 0001193125-23-161593 | 001-39536 | 23996048 | 34 | 154996 | 1 | 1 |
| 2023-06-05 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-160348 | 001-39536 | 23991297 | 34 | 172563 | 1 | 1 |
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0001209191-23-033681 | 5216 | ||||||
| 2023-06-01 | 144 | xsl144X01/primary_doc.xml | 0001231919-23-000039 | 001-39536 | 23986577 | 33 | 4625 | |||
| 2023-06-01 | 144 | xsl144X01/primary_doc.xml | 0001231919-23-000038 | 001-39536 | 23986574 | 33 | 4618 | |||
| 2023-05-19 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-148827 | 001-39536 | 23937959 | 34 | 174956 | 1 | 1 |
| 2023-05-18 | 4 | FORM 4 SUBMISSION | 0001209191-23-030661 | 5175 | ||||||
| 2023-05-15 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-145197 | 001-39536 | 23924269 | 34 | 234135 | 1 | 1 |
| 2023-05-11 | 144 | xsl144X01/primary_doc.xml | 0001231919-23-000029 | 001-39536 | 23912596 | 33 | 4230 | |||
| 2023-05-11 | 10-Q | 10-Q | 0000950170-23-021333 | 001-39536 | 23911718 | 34 | 26880791 | 1 | 1 | |
| 2023-05-08 | ARS | ARS | 0001193125-23-138235 | 001-39536 | 23897750 | 34 | 3811680 | |||
| 2023-05-08 | DEFA14A | DEFA14A | 0001193125-23-138223 | 001-39536 | 23897680 | 34 | 1110109 | |||
| 2023-05-08 | DEF 14A | DEF 14A | 0001193125-23-138221 | 001-39536 | 23897605 | 34 | 1020120 | |||
| 2023-05-04 | 424B3 | 424B3 | 0001193125-23-135884 | 333-271144 | 23888491 | 33 | 357579 | |||
| 2023-05-01 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-05-01 16:00:00 | 9999999995-23-001202 | 333-271144 | 23876470 | 33 | 1746 | ||
| 2023-04-27 | CORRESP | filename1.htm | 0001193125-23-122153 | 15072 | ||||||
| 2023-04-27 | 8-K | 8-K | 3.01,5.02 | 0001193125-23-122129 | 001-39536 | 23856842 | 34 | 160219 | 1 | 1 |
| 2023-04-27 | PRE 14A | PRE 14A | 0001193125-23-122098 | 001-39536 | 23856718 | 34 | 1019589 | |||
| 2023-04-27 | 10-K/A | 10-K/A | 0001193125-23-122086 | 001-39536 | 23856638 | 34 | 564545 | 1 | 1 | |
| 2023-04-07 | UPLOAD | filename1.pdf | 0000000000-23-003495 | 40265 | ||||||
| 2023-04-05 | S-3 | S-3 | 0001193125-23-092350 | 333-271144 | 23803078 | 33 | 732272 | |||
| 2023-03-29 | 424B5 | 424B5 | 0001193125-23-082441 | 333-260069 | 23771314 | 33 | 58684 | |||
| 2023-03-28 | S-8 | S-8 | 0001193125-23-082355 | 333-270915 | 23770794 | 33 | 77336 | |||
| 2023-03-28 | 10-K | 10-K | 0000950170-23-010343 | 001-39536 | 23770333 | 34 | 31433198 | 1 | 1 | |
| 2023-03-28 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-082174 | 001-39536 | 23769695 | 34 | 239354 | 1 | 1 |
| 2023-03-08 | 4 | FORM 4 SUBMISSION | 0001209191-23-017342 | 9976 | ||||||
| 2023-03-08 | 8-K/A | 8-K/A | 5.02 | 0001193125-23-064669 | 001-39536 | 23717006 | 34 | 160934 | 1 | 1 |
| 2023-02-09 | SC 13G/A | filing.txt | 0000315066-23-002096 | 005-91724 | 23605129 | 34 | 8016 | |||
| 2023-02-06 | 4 | FORM 4 SUBMISSION | 0001209191-23-007396 | 10637 | ||||||
| 2023-01-31 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-020343 | 001-39536 | 23572642 | 34 | 182217 | 1 | 1 |
| 2023-01-19 | 8-K | 8-K | 5.02 | 0001193125-23-010947 | 001-39536 | 23537440 | 34 | 148234 | 1 | 1 |
| 2023-01-06 | 8-K/A | 8-K/A | 5.02 | 0001193125-23-003537 | 001-39536 | 23515135 | 34 | 169952 | 1 | 1 |
| 2023-01-04 | 4 | FORM 4 SUBMISSION | 0001209191-23-001020 | 5571 | ||||||
| 2023-01-04 | 4 | FORM 4 SUBMISSION | 0001209191-23-001019 | 5592 | ||||||
| 2022-12-23 | 4 | FORM 4 SUBMISSION | 0001209191-22-062615 | 5796 | ||||||
| 2022-12-22 | 8-K | 8-K | 5.02,8.01,9.01 | 0001193125-22-311027 | 001-39536 | 221482047 | 34 | 174524 | 1 | 1 |
| 2022-11-10 | SC 13G/A | filing.txt | 0000315066-22-001829 | 005-91724 | 221375952 | 34 | 7833 | |||
| 2022-11-08 | 10-Q | 10-Q | 0001564590-22-036936 | 001-39536 | 221367430 | 34 | 26313248 | 1 | 1 | |
| 2022-11-08 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-279648 | 001-39536 | 221367183 | 34 | 239114 | 1 | 1 |
| 2022-11-07 | D | xslFormDX01/primary_doc.xml | 06b | 0001806310-22-000001 | 021-463996 | 221363884 | 33 | 12566 | ||
| 2022-11-02 | 4 | FORM 4 SUBMISSION | 0001209191-22-055263 | 7789 | ||||||
| 2022-11-02 | SC 13D/A | SC 13D/A | 0001193125-22-275814 | 005-91724 | 221353915 | 34 | 96252 | |||
| 2022-10-31 | 3 | FORM 3 SUBMISSION | 0000899243-22-034545 | 13732 | ||||||
| 2022-10-31 | SC 13D | SC 13D | 0001193125-22-273891 | 005-91724 | 221345960 | 34 | 172515 | |||
| 2022-10-31 | 8-K/A | 8-K/A | 1.01,3.02,8.01,9.01 | 0001193125-22-273298 | 001-39536 | 221343899 | 34 | 584036 | 1 | 1 |
| 2022-10-27 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-22-271108 | 001-39536 | 221338228 | 34 | 433314 | 1 | 1 |
| 2022-10-27 | 424B5 | 424B5 | 0001193125-22-271102 | 333-260069 | 221338173 | 33 | 811896 | |||
| 2022-10-25 | 8-K | 8-K | 2.02,8.01,9.01 | 0001193125-22-268414 | 001-39536 | 221329928 | 34 | 189092 | 1 | 1 |
| 2022-10-25 | 424B5 | 424B5 | 0001193125-22-268409 | 333-260069 | 221329903 | 33 | 816245 | |||
| 2022-10-25 | 8-K | 8-K | 1.01,3.02,8.01,9.01 | 0001193125-22-267999 | 001-39536 | 221327218 | 34 | 228621 | 1 | 1 |
| 2022-09-09 | 8-K | 8-K | 7.01 | 0001193125-22-242049 | 001-39536 | 221236698 | 34 | 147785 | 1 | 1 |
| 2022-08-24 | 4 | FORM 4 SUBMISSION | 0001209191-22-047353 | 5501 | ||||||
| 2022-08-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-047097 | 9113 | ||||||
| 2022-08-11 | 10-Q | 10-Q | 0001564590-22-029155 | 001-39536 | 221157038 | 34 | 26092185 | 1 | 1 | |
| 2022-08-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-217962 | 001-39536 | 221153673 | 34 | 242354 | 1 | 1 |
| 2022-07-08 | SC 13G | us8776191061_070822.txt | 0000834237-22-010356 | 005-91724 | 221075105 | 34 | 12324 | |||
| 2022-07-07 | 4 | FORM 4 SUBMISSION | 0001209191-22-041455 | 7386 | ||||||
| 2022-07-01 | 4 | FORM 4 SUBMISSION | 0001209191-22-040356 | 9192 | ||||||
| 2022-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-038692 | 5426 | ||||||
| 2022-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-038691 | 5509 | ||||||
| 2022-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-038690 | 5411 | ||||||
| 2022-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-038689 | 5393 | ||||||
| 2022-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-038687 | 5402 | ||||||
| 2022-06-22 | 4 | FORM 4 SUBMISSION | 0001209191-22-038685 | 5376 | ||||||
| 2022-06-21 | 8-K | 8-K | 5.07 | 0001193125-22-177619 | 001-39536 | 221028092 | 34 | 154114 | 1 | 1 |
| 2022-05-16 | 10-Q | 10-Q | 0001564590-22-020260 | 001-39536 | 22925736 | 34 | 28666099 | 1 | 1 | |
| 2022-05-16 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-150847 | 001-39536 | 22925390 | 34 | 252182 | 1 | 1 |
| 2022-04-28 | DEFA14A | DEFA14A | 0001193125-22-127848 | 001-39536 | 22867675 | 34 | 171537 | |||
| 2022-04-28 | DEF 14A | DEF 14A | 0001193125-22-127828 | 001-39536 | 22867609 | 34 | 772209 | |||
| 2022-04-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-023863 | 5522 | ||||||
| 2022-04-08 | 4 | FORM 4 SUBMISSION | 0001209191-22-023862 | 5596 | ||||||
| 2022-03-31 | 424B5 | 424B5 | 0001193125-22-091855 | 333-260069 | 22792973 | 33 | 12249 | |||
| 2022-03-31 | S-8 | S-8 | 0001193125-22-091836 | 333-264025 | 22792915 | 33 | 82991 | |||
| 2022-03-31 | 10-K | 10-K - UPDATED | 0001564590-22-012782 | 001-39536 | 22789418 | 34 | 36146061 | 1 | 1 | |
| 2022-03-31 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-090671 | 001-39536 | 22789112 | 34 | 269826 | 1 | 1 |
| 2022-02-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-013163 | 5600 | ||||||
| 2022-02-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-013160 | 5526 | ||||||
| 2022-02-25 | 4 | FORM 4 SUBMISSION | 0001209191-22-013156 | 5585 | ||||||
| 2022-02-09 | SC 13G/A | filing.txt | 0000315066-22-001227 | 005-91724 | 22604651 | 34 | 8435 | |||
| 2022-02-07 | SC 13G/A | us8776191061_020722.txt | 0000834237-22-007855 | 005-91724 | 22598015 | 34 | 13402 | |||
| 2022-02-04 | 4 | FORM 4 SUBMISSION | 0001209191-22-007126 | 13760 | ||||||
| 2022-02-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-006652 | 4535 | ||||||
| 2022-02-03 | 4 | FORM 4 SUBMISSION | 0001209191-22-006641 | 4631 | ||||||
| 2022-01-31 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-022338 | 001-39536 | 22571296 | 34 | 191699 | 1 | 1 |
| 2022-01-27 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-019000 | 001-39536 | 22559879 | 34 | 184315 | 1 | 1 |
| 2021-12-08 | 4 | FORM 4 SUBMISSION | 0001209191-21-068510 | 8629 | ||||||
| 2021-11-29 | 4 | FORM 4 SUBMISSION | 0001209191-21-067005 | 7200 | ||||||
| 2021-11-24 | 4 | FORM 4 SUBMISSION | 0001209191-21-066702 | 7200 | ||||||
| 2021-11-10 | 10-Q | 10-Q | 0001564590-21-056225 | 001-39536 | 211397101 | 34 | 22742099 | 1 | 1 | |
| 2021-11-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-325269 | 001-39536 | 211394402 | 34 | 281806 | 1 | 1 |
| 2021-10-14 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2021-10-14 16:00:00 | 9999999995-21-003891 | 333-260069 | 211324687 | 33 | 1747 | ||
| 2021-10-12 | CORRESP | filename1.htm | 0001193125-21-296887 | 8086 | ||||||
| 2021-10-12 | UPLOAD | filename1.pdf | 0000000000-21-012325 | 40224 | ||||||
| 2021-10-05 | S-3 | S-3 | 0001193125-21-292221 | 333-260069 | 211307568 | 33 | 1532751 | |||
| 2021-10-05 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-291535 | 001-39536 | 211305139 | 34 | 175646 | 1 | 1 |
| 2021-09-24 | SC 13G | taysha13ga.htm | 0001019231-21-000010 | 005-91724 | 211273528 | 34 | 9632 | |||
| 2021-08-20 | 4 | FORM 4 SUBMISSION | 0001209191-21-052824 | 12734 | ||||||
| 2021-08-16 | 10-Q | 10-Q | 0001564590-21-044462 | 001-39536 | 211174762 | 34 | 10899476 | 1 | 1 | |
| 2021-08-16 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-21-246904 | 001-39536 | 211174482 | 34 | 291885 | 1 | 1 |
| 2021-07-01 | 4 | FORM 4 SUBMISSION | 0001209191-21-044563 | 16409 | ||||||
| 2021-06-29 | 8-K | 8-K | 7.01,9.01 | 0001193125-21-202639 | 001-39536 | 211055721 | 34 | 26806207 | ||
| 2021-06-28 | 8-K | FORM 8-K | 7.01,9.01 | 0001193125-21-201075 | 001-39536 | 211049965 | 34 | 36980288 | ||
| 2021-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-042112 | 5487 | ||||||
| 2021-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-042110 | 5389 | ||||||
| 2021-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-042107 | 5371 | ||||||
| 2021-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-042106 | 5380 | ||||||
| 2021-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-042101 | 5404 | ||||||
| 2021-06-21 | 4 | FORM 4 SUBMISSION | 0001209191-21-042087 | 5354 | ||||||
| 2021-06-17 | 8-K | 8-K | 5.07 | 0001193125-21-193328 | 001-39536 | 211025703 | 34 | 21399 | ||
| 2021-05-24 | 4 | FORM 4 SUBMISSION | 0001209191-21-035165 | 6029 | ||||||
| 2021-05-17 | 4 | FORM 4 SUBMISSION | 0001209191-21-033009 | 7200 | ||||||
| 2021-05-11 | S-8 | S-8 | 0001193125-21-157741 | 333-256013 | 21912387 | 33 | 62836 | |||
| 2021-05-11 | 10-Q | 10-Q | 0001564590-21-026559 | 001-39536 | 21911528 | 34 | 5870177 | 1 | ||
| 2021-05-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-156965 | 001-39536 | 21909596 | 34 | 106112 | ||
| 2021-04-29 | DEF 14A | DEF 14A | 0001193125-21-140758 | 001-39536 | 21871826 | 34 | 720950 | |||
| 2021-04-14 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-21-116308 | 001-39536 | 21825925 | 34 | 24385037 | ||
| 2021-04-12 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-112434 | 001-39536 | 21819354 | 34 | 45542 | ||
| 2021-03-09 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-073904 | 001-39536 | 21724096 | 34 | 34762 | ||
| 2021-03-05 | 8-K/A | 8-K/A | 2.02,9.01 | 0001193125-21-071533 | 001-39536 | 21718879 | 34 | 74071 | ||
| 2021-03-03 | 10-K | 10-K | 0001564590-21-010433 | 001-39536 | 21707362 | 34 | 10472968 | 1 | ||
| 2021-03-03 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-066597 | 001-39536 | 21707218 | 34 | 86919 | ||
| 2021-02-16 | 5 | FORM 5 SUBMISSION | 0001209191-21-010878 | 6127 | ||||||
| 2021-02-16 | SC 13G | taysha13g.htm | 0001019231-21-000007 | 005-91724 | 21635711 | 34 | 9419 | |||
| 2021-02-12 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-041656 | 001-39536 | 21628097 | 34 | 42074 | ||
| 2021-02-08 | SC 13G/A | filing.txt | 0000315066-21-001299 | 005-91724 | 21599841 | 34 | 8387 | |||
| 2021-02-02 | SC 13G | us8776191061_020221.txt | 0000834237-21-007057 | 005-91724 | 21580776 | 34 | 13150 | |||
| 2021-02-01 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-023671 | 001-39536 | 21574332 | 34 | 56339 | ||
| 2021-01-20 | 4 | FORM 4 SUBMISSION | 0001209191-21-004573 | 5495 | ||||||
| 2021-01-20 | 4 | FORM 4 SUBMISSION | 0001209191-21-004572 | 5512 | ||||||
| 2021-01-20 | 4 | FORM 4 SUBMISSION | 0001209191-21-004571 | 5438 | ||||||
| 2021-01-19 | 8-K | 8-K | 8.01,9.01 | 0001193125-21-010793 | 001-39536 | 21533916 | 34 | 41227 | ||
| 2021-01-15 | 8-K | 8-K | 1.01,2.03 | 0001193125-21-010133 | 001-39536 | 21532510 | 34 | 20225 | ||
| 2020-12-21 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-322291 | 001-39536 | 201402372 | 34 | 43559 | ||
| 2020-12-17 | 8-K | 8-K | 1.01,2.03,8.01,9.01 | 0001193125-20-320071 | 001-39536 | 201396296 | 34 | 51403 | ||
| 2020-12-03 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-308933 | 001-39536 | 201365686 | 34 | 36195 | ||
| 2020-11-24 | 4 | FORM 4 SUBMISSION | 0001209191-20-060227 | 5313 | ||||||
| 2020-11-24 | 4 | FORM 4 SUBMISSION | 0001209191-20-060225 | 5289 | ||||||
| 2020-11-24 | 3 | FORM 3 SUBMISSION | 0001209191-20-060222 | 6601 | ||||||
| 2020-11-24 | 3 | FORM 3 SUBMISSION | 0001209191-20-060221 | 6560 | ||||||
| 2020-11-24 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-20-301981 | 001-39536 | 201339880 | 34 | 35773 | ||
| 2020-11-12 | 10-Q | 10-Q | 0001564590-20-053602 | 001-39536 | 201307140 | 34 | 5445692 | 1 | ||
| 2020-11-12 | 8-K | 8-K | 2.01,9.01 | 0001193125-20-291719 | 001-39536 | 201307119 | 34 | 71289 | ||
| 2020-11-05 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-286290 | 001-39536 | 201288831 | 34 | 30075 | ||
| 2020-11-04 | 8-K | 8-K | 1.01 | 0001193125-20-285213 | 001-39536 | 201285356 | 34 | 20254 | ||
| 2020-10-27 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-277634 | 001-39536 | 201262146 | 34 | 29375 | ||
| 2020-10-14 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-269048 | 001-39536 | 201238294 | 34 | 37147 | ||
| 2020-10-13 | SC 13G | filing.txt | 0000315066-20-001803 | 005-91724 | 201235153 | 34 | 8381 | |||
| 2020-10-07 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-265562 | 001-39536 | 201229213 | 34 | 38776 | ||
| 2020-10-05 | SC 13D | ACQUISITION OF BENEFICIAL OWNERSHIP | 0001387131-20-008773 | 005-91724 | 201224588 | 34 | 88089 | |||
| 2020-10-05 | SC 13D | ACQUISITION OF BENEFICIAL OWNERSHIP | 0001387131-20-008761 | 005-91724 | 201224268 | 34 | 75296 | |||
| 2020-09-30 | 4 | FORM 4 SUBMISSION | 0001209191-20-052463 | 7019 | ||||||
| 2020-09-30 | 4 | FORM 4 SUBMISSION | 0001209191-20-052462 | 11544 | ||||||
| 2020-09-30 | 4 | FORM 4 SUBMISSION | 0001209191-20-052460 | 6946 | ||||||
| 2020-09-30 | 4 | FORM 4 SUBMISSION | 0001209191-20-052459 | 15878 | ||||||
| 2020-09-29 | 8-K | 8-K | 5.03,9.01 | 0001193125-20-257858 | 001-39536 | 201209270 | 34 | 48844 | ||
| 2020-09-29 | S-8 | S-8 | 0001193125-20-257854 | 333-249130 | 201209249 | 33 | 87359 | |||
| 2020-09-25 | 4 | FORM 4 SUBMISSION | 0001209191-20-052116 | 4966 | ||||||
| 2020-09-25 | 4 | FORM 4 SUBMISSION | 0001209191-20-052115 | 5282 | ||||||
| 2020-09-25 | 4 | FORM 4 SUBMISSION | 0001209191-20-052114 | 5300 | ||||||
| 2020-09-25 | 4 | FORM 4 SUBMISSION | 0001209191-20-052113 | 5265 | ||||||
| 2020-09-25 | 4 | FORM 4 SUBMISSION | 0001209191-20-052112 | 5398 | ||||||
| 2020-09-25 | 4 | FORM 4 SUBMISSION | 0001209191-20-052110 | 4901 | ||||||
| 2020-09-25 | 424B4 | 424B4 | 0001193125-20-253550 | 333-248559 | 201196204 | 33 | 4871479 | |||
| 2020-09-23 | SEC STAFF LETTER | filename1.pdf | 9999999997-20-004757 | 275521 | ||||||
| 2020-09-23 | EFFECT | xslEFFECTX01/primary_doc.xml | S-1,,2020-09-23 16:00:00 | 9999999995-20-002541 | 333-248559 | 201193428 | 33 | 1687 | ||
| 2020-09-23 | 3 | FORM 3 SUBMISSION | 0001209191-20-051744 | 8941 | ||||||
| 2020-09-23 | 3 | FORM 3 SUBMISSION | 0001209191-20-051743 | 8015 | ||||||
| 2020-09-23 | 3 | FORM 3 SUBMISSION | 0001209191-20-051742 | 9510 | ||||||
| 2020-09-23 | 3 | FORM 3 SUBMISSION | 0001209191-20-051741 | 9204 | ||||||
| 2020-09-23 | 3 | FORM 3 SUBMISSION | 0001209191-20-051740 | 10938 | ||||||
| 2020-09-23 | 3 | FORM 3 SUBMISSION | 0001209191-20-051739 | 7958 | ||||||
| 2020-09-23 | 3 | FORM 3 SUBMISSION | 0001209191-20-051738 | 6536 | ||||||
| 2020-09-23 | S-1MEF | S-1MEF | 0001193125-20-252504 | 333-249001 | 201193037 | 33 | 53161 | |||
| 2020-09-23 | CERT | 8A_Cert_TSHA2.pdf | 0001354457-20-000511 | 001-39536 | 201190436 | 34 | 86300 | |||
| 2020-09-21 | CORRESP | filename1.htm | 0001193125-20-250161 | 10009 | ||||||
| 2020-09-21 | CORRESP | filename1.htm | 0001193125-20-250155 | 13467 | ||||||
| 2020-09-18 | 8-A12B | 8-A12B | 0001193125-20-249136 | 001-39536 | 201184264 | 34 | 14769 | |||
| 2020-09-18 | S-1/A | S-1/A | 0001193125-20-248359 | 333-248559 | 201182633 | 33 | 5144659 | |||
| 2020-09-17 | CORRESP | filename1.htm | 0001193125-20-247569 | 25294 | ||||||
| 2020-09-17 | S-1/A | S-1/A | 0001193125-20-247565 | 333-248559 | 201180062 | 33 | 6184894 | |||
| 2020-09-16 | UPLOAD | filename1.pdf | 0000000000-20-008748 | 47956 | ||||||
| 2020-09-11 | SEC STAFF LETTER | filename1.pdf | 9999999997-20-004642 | 228449 | ||||||
| 2020-09-08 | CORRESP | filename1.htm | 0001193125-20-241070 | 39635 | ||||||
| 2020-09-08 | S-1/A | S-1/A | 0001193125-20-241062 | 333-248559 | 201164579 | 33 | 4970400 | |||
| 2020-09-02 | S-1 | S-1 | 0001193125-20-238197 | 333-248559 | 201157511 | 33 | 6651742 |
One latest value per concept from companyfacts (247 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 326.05M | 2026-11-12 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 544.80M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 9.42M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-22 | 0001193125-26-168525 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 2.12M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-22 | 0001193125-26-168525 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 18.26M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-22 | 0001193125-26-168525 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 4.10M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-22 | 0001193125-26-168525 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 310.73 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-22 | 0001193125-26-168525 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 31,763 | 2026-06-25 | 424B5 | 2026-06-25 | 0001193125-26-282846 | |||
| ffd | NrrtvMaxAggtOfferingPric | NrrtvMaxAggtOfferingPric | USD | 230.00M | 2026-06-25 | 424B5 | 2026-06-25 | 0001193125-26-282846 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 31,763 | 2026-06-25 | 424B5 | 2026-06-25 | 0001193125-26-282846 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 230.00M | 2026-06-25 | 424B5 | 2026-06-25 | 0001193125-26-282846 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-06-25 | 424B5 | 2026-06-25 | 0001193125-26-282846 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-06-25 | 424B5 | 2026-06-25 | 0001193125-26-282846 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 5.59M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 17.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 2.73M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053602 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 1.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 5.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | 2.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 1.19B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 17.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 15.14M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012782 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 1.64M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 17.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 39.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 4.80M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | Assets | Assets | USD | 435.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 426.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 420.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | AssetsHeldForSaleNotPartOfDisposalGroupCurrent | Assets Held-for-sale, Not Part of Disposal Group, Current | USD | 2.00M | 2023-12-31 | 2024 | FY | 10-K | 2025-02-26 | 0000950170-25-027348 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 25,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | CapitalLeaseObligationsIncurred | Lease Obligation Incurred | USD | 26.25M | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010343 |
| us-gaap | Cash | Cash | USD | 197.40M | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001564590-21-044462 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 422.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 188.80M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-10 | 0001564590-21-056225 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 423.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 100.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | CashEquivalentsAtCarryingValue | Cash Equivalents, at Carrying Value | USD | 317.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 700.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 325.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 325.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 3,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -125.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 1.10M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-13 | 0000950170-24-126416 |
| us-gaap | CumulativeEarningsDeficit | Cumulative Earnings (Deficit) | USD | 200,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033484 | |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 50.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.07 | 2021-08-12 | 2024 | Q2 | 10-Q | 2024-08-12 | 0000950170-24-095082 | |
| us-gaap | DebtInstrumentUnamortizedDiscount | Debt Instrument, Unamortized Discount | USD | 1.45M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0000950170-23-063734 | |
| us-gaap | DebtInstrumentUnamortizedDiscountNoncurrent | Debt Instrument, Unamortized Discount, Noncurrent | USD | 3.00M | 2023-12-31 | 2024 | FY | 10-K | 2025-02-26 | 0000950170-25-027348 | |
| us-gaap | DeferredCostsLeasingNetNoncurrent | Deferred Costs, Leasing, Net, Noncurrent | USD | 630,000 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001564590-22-036936 | |
| us-gaap | DeferredOfferingCosts | Deferred Offering Costs | USD | 110,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 28.90M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0000950170-23-021333 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 9.77M | 2024-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 2.95M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0000950170-23-063734 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 4.96M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 140.41M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 34.17M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 69.45M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 13.85M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 27.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits | USD | 5.77M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseOther | Deferred Tax Assets, Tax Deferred Expense, Other | USD | 65,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals | USD | 1.94M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 137.72M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 2.68M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 2.06M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 619,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | DeferredTaxLiabilitiesPropertyPlantAndEquipment | Deferred Tax Liabilities, Property, Plant and Equipment | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-26 | 0000950170-25-027348 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 600,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | Depreciation | Depreciation | USD | 843,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 140.53M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0000950170-23-063734 | |
| us-gaap | DueToRelatedPartiesCurrent | Due to Related Parties, Current | USD | 60,000 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053602 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.34 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -1.31 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-16 | 0001564590-22-020260 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.34 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.231 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.011 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseResearchAndDevelopment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Research and Development, Percent | pure | 0.059 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-26 | 0000950170-25-027348 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.013 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.023 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-26 | 0000950170-25-027348 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | 0.15 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-26 | 0000950170-25-027348 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.061 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 7.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 463,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | FinanceLeaseLiability | Finance Lease, Liability | USD | 57,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | FinanceLeaseLiabilityCurrent | Finance Lease, Liability, Current | USD | 57,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 57,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-04 | 0001193125-25-263506 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDue | Finance Lease, Liability, Payment, Due | USD | 58,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueNextTwelveMonths | Finance Lease, Liability, to be Paid, Year One | USD | 399,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearFive | Finance Lease, Liability, to be Paid, Year Five | USD | 73,000 | 2022-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010343 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearFour | Finance Lease, Liability, to be Paid, Year Four | USD | 73,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033484 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearThree | Finance Lease, Liability, to be Paid, Year Three | USD | 325,000 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033484 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueYearTwo | Finance Lease, Liability, to be Paid, Year Two | USD | 399,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-26 | 0000950170-25-027348 | |
| us-gaap | FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear | Finance Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 58,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | FinanceLeaseLiabilityUndiscountedExcessAmount | Finance Lease, Liability, Undiscounted Excess Amount | USD | 1,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | FinanceLeaseWeightedAverageDiscountRatePercent | Finance Lease, Weighted Average Discount Rate, Percent | pure | 0.109 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | -4.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | 100,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | GainLossOnSalesOfAssetsAndAssetImpairmentCharges | Gain (Loss) on Sale of Assets and Asset Impairment Charges | USD | -4.80M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | GainLossOnTerminationOfLease | Gain (Loss) on Termination of Lease | USD | 3.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | -1.40M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-26 | 0000950170-25-027348 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 34.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 25.17M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -22.89M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 1.20M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 1.41M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 9,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 6.68M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 2.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 1.58M | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053602 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -4.29M | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | IncreaseDecreaseInDueToRelatedParties | Increase (Decrease) in Due to Related Parties | USD | -8,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010343 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | -1.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | 604,000 | 2020-01-01 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053602 |
| us-gaap | InterestExpense | Interest Expense | USD | 56,000 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-12 | 0000950170-24-095082 |
| us-gaap | InterestExpenseLongTermDebt | Interest Expense, Long-term Debt | USD | 4.90M | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-26 | 0000950170-25-027348 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 19,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | 3.13M | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-12 | 0000950170-24-095082 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 4.33M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 8.81M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | LaborAndRelatedExpense | Labor and Related Expense | USD | 49.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | LeaseCost | Lease, Cost | USD | 2.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 9.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 11.40M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 1.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 3.52M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 1.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 1.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 1.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 493,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 2.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | Liabilities | Liabilities | USD | 78.06M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 435.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 22.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | LiabilitiesFairValueDisclosure | Financial and Nonfinancial Liabilities, Fair Value Disclosure | USD | 49.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 38.35M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0000950170-23-042089 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 6.67M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0000950170-23-063734 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive | Long-Term Debt, Maturity, Year Five | USD | 38.03M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 38.03M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 11.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 20.00M | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0000950170-23-063734 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 47.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 218.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -3.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -114.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -128.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -128.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 | Noncash or Part Noncash Acquisition, Fixed Assets Acquired | USD | 606,000 | 2021-01-01 | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010343 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 4.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 132.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -132.71M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 1.87M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 1.00M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-08 | 0001564590-22-036936 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 7.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 6.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 3.02M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 6.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 796,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 52.15M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010343 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 4.20M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010343 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 3.87M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010343 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 4.37M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010343 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 4.30M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010343 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 30.56M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010343 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 4.85M | 2021-12-31 | 2022 | FY | 10-K | 2023-03-28 | 0000950170-23-010343 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.107 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 217.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 515,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 659,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 48,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 1.49M | 2021-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012782 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 1.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | -155,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | OtherNonoperatingExpense | Other Nonoperating Expense | USD | 8,000 | 2023-01-01 | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-11 | 0000950170-23-021333 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -187,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | PaymentsForProceedsFromOtherInvestingActivities | Payments for (Proceeds from) Other Investing Activities | USD | -131,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 18,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 387,000 | 2023-01-01 | 2023-06-30 | 2024 | Q2 | 10-Q | 2024-08-12 | 0000950170-24-095082 |
| us-gaap | PaymentsToAcquireInProcessResearchAndDevelopment | Payments to Acquire in Process Research and Development | USD | 3.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 466,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 3.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 604,000 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-12 | 0001564590-20-053602 | |
| us-gaap | PrepaidInsurance | Prepaid Insurance | USD | 17,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 165.85M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012782 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 500,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-26 | 0000950170-25-027348 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 18.60M | 2020-01-01 | 2020-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001564590-21-044462 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 225,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | ProceedsFromPaymentsForOtherFinancingActivities | Proceeds from (Payments for) Other Financing Activities | USD | -166,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 1.67M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012782 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 2.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 463,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -128.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | PropertyPlantAndEquipmentDisposals | Property, Plant and Equipment, Disposals | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 7.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 2.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits | Property Subject to or Available for Operating Lease, Number of Units | sqft | 187,500 | 2020-12-17 | 2020 | FY | 10-K | 2021-03-03 | 0001564590-21-010433 | |
| us-gaap | RepaymentsOfRelatedPartyDebt | Repayments of Related Party Debt | USD | 1.67M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012782 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 101.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 3.50M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-14 | 0000950170-23-042089 |
| us-gaap | RestrictedCash | Restricted Cash | USD | 165,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 449,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 165,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.35 | 2022-01-01 | 2022-03-31 | 2022 | Q2 | 10-Q | 2022-08-11 | 0001564590-22-029155 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -839.48M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | Revenues | Revenues | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | USD | 23.43M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033484 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 159,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | SegmentReportingOtherItemAmount | SegmentReportingOtherItemAmount | USD | 11.76M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | SettlementOfAssetRetirementObligationsThroughNoncashPaymentsAmount | Settlement of Asset Retirement Obligations Through Noncash Payments, Amount | USD | 449,000 | 2023-01-01 | 2023-12-31 | 2024 | FY | 10-K | 2025-02-26 | 0000950170-25-027348 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 17.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardDiscountFromMarketPriceOfferingDate | Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date | pure | 0.15 | 2022-02-01 | 2022-02-28 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate | Share-based Compensation Arrangement by Share-based Payment Award, Maximum Employee Subscription Rate | pure | 0.85 | 2022-02-28 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumNumberOfSharesPerEmployee | Share-based Compensation Arrangement by Share-based Payment Award, Maximum Number of Shares Per Employee | shares | 1,800 | 2022-02-01 | 2022-02-28 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant | Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant | shares | 3.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 7.52 | 2020-06-30 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012782 | |
| us-gaap | SignificantChangeInUnrecognizedTaxBenefitsIsReasonablyPossibleAmountOfUnrecordedBenefit | Significant Change in Unrecognized Tax Benefits is Reasonably Possible, Amount of Unrecorded Benefit | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 356.97M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 177,000 | 2020-01-01 | 2020-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001564590-21-044462 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 142.24M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012782 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 463,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 11.61M | 2022-01-01 | 2022-09-30 | 2023 | Q3 | 10-Q | 2023-11-14 | 0000950170-23-063734 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 2.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 15.65M | 2020-07-28 | 2021 | FY | 10-K | 2022-03-31 | 0001564590-22-012782 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-03 | 0001564590-21-010433 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 7.80M | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033484 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | UnrecognizedTaxBenefitsPeriodIncreaseDecrease | Unrecognized Tax Benefits, Period Increase (Decrease) | USD | 400,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-19 | 0000950170-24-033484 |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 23.60M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 595,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | WarrantsAndRightsOutstanding | Warrants and Rights Outstanding | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-19 | 0001193125-26-115202 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 380.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 38.17M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-16 | 0001564590-22-020260 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 380.74M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001193125-26-456949 |